Hypercalcemia News and Research

RSS
Hypercalcemia or increased blood level of calcium is calcium found in a concentration that is higher than the usual range of 8.5 to 10.2 mg/dL. However, this normal value may vary slightly between different laboratories due to differences in protocols.

Further Reading

Surgery more effective than drug therapy in patients with tertiary hyperparathyroidism

Surgery more effective than drug therapy in patients with tertiary hyperparathyroidism

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Amgen announces MAA submission to EMA for novel calcimimetic agent etelcalcetide

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Amgen's XGEVA (denosumab) receives FDA approval for treatment of hypercalcemia of malignancy

Hospira launches Paricalcitol Injection

Hospira launches Paricalcitol Injection

Calcium, vitamin D supplements may send blood levels too high for some women

Calcium, vitamin D supplements may send blood levels too high for some women

Drugs used to treat osteoporosis appear to prevent cell membrane repair

Drugs used to treat osteoporosis appear to prevent cell membrane repair

Hope in sight for sufferers of chronic renal disease

Hope in sight for sufferers of chronic renal disease

Recombinant hormone could REPLACE calcium supplements

Recombinant hormone could REPLACE calcium supplements

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Consortium database model compares favorably for RCC prognosis

Consortium database model compares favorably for RCC prognosis

Cytochroma commences CTAP101 phase 3 study in secondary hyperparathyroidism

Cytochroma commences CTAP101 phase 3 study in secondary hyperparathyroidism

Mushroom compound lengthens lives of dogs with cancer, has human potential

Mushroom compound lengthens lives of dogs with cancer, has human potential

Safe vitamin D treatment without raising calcium levels

Safe vitamin D treatment without raising calcium levels

Vitamin D and calcium supplements could increase risk of kidney stones

Vitamin D and calcium supplements could increase risk of kidney stones

NexGen receives U.S. patent allowance for novel pathogenesis based seizure treatment

NexGen receives U.S. patent allowance for novel pathogenesis based seizure treatment

Paricalcitol does not improve clinical outcomes for patients with CKD

Paricalcitol does not improve clinical outcomes for patients with CKD

New discovery paves way for genetic screening test

New discovery paves way for genetic screening test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.